Abel De La Rosa Insider Profile
11 Followers
Abel De La Rosa, Director at Dogwood Therapeutics, holds 4.00K shares in Dogwood Therapeutics (Ticker: DWTX). Most recently, Abel De La Rosa Bought 4,000 shares of Dogwood Therapeutics on Jan 07, 2022 for an estimated value of $23.56K.
Abel De La Rosa's Trading History
| DWTXDogwood Therapeutics | Jan 07, 2022 | Director | Informative Buy | 23.56K | $4.44K | |
You May Also Like
Abel De La Rosa insider profile FAQ
What stocks does Abel De La Rosa hold?
Abel De La Rosa holds: DWTX stocks.
What was Abel De La Rosa’s latest transaction?
Abel De La Rosa’s latest transaction was an Informative Buy of $23.56K.
What is Abel De La Rosa's role in Dogwood Therapeutics?
Abel De La Rosa's role in Dogwood Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
